Lung & Respiratory Disease Treatment in India — Breathe Freely Again
Respiratory diseases are among the most common chronic conditions globally. India’s pulmonology departments offer comprehensive care for the full spectrum — from asthma and COPD to interstitial lung disease, pulmonary fibrosis, and pulmonary hypertension. Indian pulmonologists are trained in advanced bronchoscopic techniques including EBUS, cryobiopsy, bronchial thermoplasty for severe asthma, and navigational bronchoscopy. For patients with tuberculosis — common in the Gulf region — India’s chest medicine specialists are globally recognised for TB management including drug-resistant TB (MDR-TB and XDR-TB). Pulmonary rehabilitation programmes improve lung function in COPD and post-COVID lung damage patients.
Why India? Key Points
- Comprehensive respiratory workup: spirometry, CT chest, HRCT, V/Q scan, EBUS
- Bronchial thermoplasty for severe asthma — not widely available in Gulf
- MDR-TB and XDR-TB treatment expertise — world-leading specialists
- Biologic therapy for asthma at 50–60% lower cost
- Pulmonary rehabilitation for COPD and post-COVID recovery
- Lung transplant available at select partner hospitals
Sub-Treatments Covered
- Asthma Management & Bronchial Thermoplasty
- COPD Treatment & Pulmonary Rehabilitation
- Tuberculosis Treatment (TB/MDR-TB)
- Interstitial Lung Disease
- Pulmonary Hypertension
- Lung Transplant
- EBUS Bronchoscopy
🏥 Best Hospitals forLung & Respiratory Disease Treatment in India
Fortis Memorial Research Institute is a JCI-accredited quaternary-care hospital in Gurgaon, consistently ranked among India's top 5 smart hospitals, handling the country's most complex referral cases in cardiac, neurology, and oncology.
Medanta — The Medicity in Gurgaon is India's highest-ranked private hospital, treating over 20,000 international patients annually from 130 countries, with 1,391 beds and 40 operating theatres across a 43-acre campus.
👨⚕️ Top Doctors for Lung & Respiratory Disease Treatment in India
Frequently Asked Questions
Asthma, COPD, tuberculosis (MDR-TB), pulmonary fibrosis, interstitial lung disease, sarcoidosis, pulmonary hypertension, sleep apnoea, post-COVID lung complications.
Yes. India has world-leading TB expertise including drug-resistant TB (MDR-TB and XDR-TB). WHO guideline protocols with excellent results.
Outpatient bronchoscopic procedure using thermal energy to reduce airway smooth muscle, significantly reducing severe asthma attacks. Performed over 3 sessions.
Asthma workup: $500–$1,500. COPD treatment: $2,000–$5,000. Bronchial thermoplasty:$4,000–$7,000. Biologic per injection: $300–$600.
Lung damage from COPD cannot be reversed, but pulmonary rehabilitation significantly improves breathing capacity, exercise tolerance, and quality of life.
